TY - JOUR
T1 - Design and application of magnetic-based theranostic nanoparticle systems
AU - Wadajkar, Aniket S.
AU - Menon, Jyothi U.
AU - Kadapure, Tejaswi
AU - Tran, Richard T.
AU - Yang, Jian
AU - Nguyen, Kytai T.
PY - 2013
Y1 - 2013
N2 - Recently, magnetic-based theranostic nanoparticle (MBTN) systems have been studied, researched, and applied extensively to detect and treat various diseases including cancer. Theranostic nanoparticles are advantageous in that the diagnosis and treatment of a disease can be performed in a single setting using combinational strategies of targeting, imaging, and/or therapy. Of these theranostic strategies, magnetic-based systems containing magnetic nanoparticles (MNPs) have gained popularity because of their unique ability to be used in magnetic resonance imaging, magnetic targeting, hyperthermia, and controlled drug release. To increase their effectiveness, MNPs have been decorated with a wide variety of materials to improve their biocompatibility, carry therapeutic payloads, encapsulate/bind imaging agents, and provide functional groups for conjugation of biomolecules that provide receptor-mediated targeting of the disease. This review summarizes recent patents involving various polymer coatings, imaging agents, therapeutic agents, targeting mechanisms, and applications along with the major requirements and challenges faced in using MBTN for disease management.
AB - Recently, magnetic-based theranostic nanoparticle (MBTN) systems have been studied, researched, and applied extensively to detect and treat various diseases including cancer. Theranostic nanoparticles are advantageous in that the diagnosis and treatment of a disease can be performed in a single setting using combinational strategies of targeting, imaging, and/or therapy. Of these theranostic strategies, magnetic-based systems containing magnetic nanoparticles (MNPs) have gained popularity because of their unique ability to be used in magnetic resonance imaging, magnetic targeting, hyperthermia, and controlled drug release. To increase their effectiveness, MNPs have been decorated with a wide variety of materials to improve their biocompatibility, carry therapeutic payloads, encapsulate/bind imaging agents, and provide functional groups for conjugation of biomolecules that provide receptor-mediated targeting of the disease. This review summarizes recent patents involving various polymer coatings, imaging agents, therapeutic agents, targeting mechanisms, and applications along with the major requirements and challenges faced in using MBTN for disease management.
UR - http://www.scopus.com/inward/record.url?scp=84876921213&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84876921213&partnerID=8YFLogxK
U2 - 10.2174/1874764711306010007
DO - 10.2174/1874764711306010007
M3 - Review article
C2 - 23795343
AN - SCOPUS:84876921213
VL - 6
SP - 47
EP - 57
JO - Recent Patents on Biomedical Engineering
JF - Recent Patents on Biomedical Engineering
SN - 1874-7647
IS - 1
ER -
